Abstract

Hypertension, often termed the "silent killer," poses a significant public health challenge in India. Recognizing the urgency of addressing this silent killer, India has made efforts to increase awareness and implement strategies for hypertension control. With an estimated 200 million adults affected by this condition, it poses a considerable burden on individuals, families, and the healthcare system.India has implemented a multifaceted approach known as the India Hypertension Control Initiative (IHCI), a joint initiative involving various partners, to combat this growing health concern. Its primary objective is to improve the management of hypertension in primary healthcare facilities, aligning with the current screening program in place. By implementing evidence based strategies and reinforcing the fundamental aspects of hypertension control, IHCI aims to drive progress in tackling non-communicable diseases in India by collaborating with key stakeholders such as the Ministry of Health & Family Welfare, State Governments, ICMR, and WHO India. By working together, IHCI and its partners strive to achieve the targets set by the Government of India in addressing the burden of non-communicable diseases and improving the health outcomes of the population. In this comprehensive review article, a critical examination is conducted, delving deep into the strategies, successes, challenges, and pivotal transition from mere awareness to impactful action in the realm of hypertension control, specifically within the unique and intricate fabric of the Indian context. It underscores the importance of addressing hypertension comprehensively, from awareness campaigns to sustained healthcare interventions, while highlighting lessons for global public health efforts.

• 1.   World Health Organization. NonCommunicable Diseases. (2022). Available from: who.int/newsroom/fact-sheets/detail/noncommunicable-diseases [Accessed 20th April 2023].
• 2.   Global report on hypertension: the race against a silent killer [Internet]. [cited 2023 Sep 21]. Available from: https://www.who.int/publications/i/item/9789240081062
• 3.   Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, Abd-Allah F, Abdelalim A, Abraha HN, Abu-Rmeileh NM, Adebayo OM. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019 May 1;18(5):439-58.
• 4.   Gupta R, Xavier D. Hypertension: The most important non communicable disease risk factor in India. Indian heart journal. 2018 Jul 1;70(4):565-72.
• 5.   Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulle AM, Abera SF, Aboyans V, Abu-Raddad LJ. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017 Sep 16;390(10100):1345-422.
• 6.   Institute for Health Metrics and Evaluation, 2015 data.
• 7.   Kaur P, Kunwar A, Sharma M, Durgad K, Gupta S, Bhargava B. The India Hypertension Control Initiative–early outcomes in 26 districts across Àve states of India, 2018-2020. Journal of Human Hypertension. 2022 Aug 9:1-8.
• 8.   Kaur P, Kunwar A, Sharma M, Mitra J, Das C, Swasticharan L, Chakma T, DipakBangar S, Venkatasamy V, Dharamsoth R, Purohit S. India hypertension control initiative-hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics. The Journal of Clinical Hypertension. 2021 Apr;23(4):720-9.
• 9.   Kunwar A, Durgad K, Kaur P, Sharma M, Swasticharan L, Mallela M, Saxena A, Tayade S, Gill S, Gopal BK, Pathni AK. Interventions to ensure the continuum of care for hypertension during the COVID-19 pandemic in Àve Indian states India Hypertension Control Initiative. Global Heart. 2021;16(1).
• 10.   Gupta R, Guptha S. Strategies for initial management of hypertension.
• 11.   Awrence L, Ppel JA, Homas T, Oore JM, Va E, Barzanek O, et al. A Clinical Trial of the effects of Dietary Patterns on Blood Pressure Abstract. The New England Journal of Medicine © Copyright. 1997;336.
• 12.   Nguyen Q, Dominguez J, Nguyen L, Gullapalli N. Hypertension Management: An Update. Am Health Drug BeneÀts [Internet]. 2010 Jan [cited 2023 Sep 26];3(1):47. Available from: /pmc/articles/PMC4106550/
• 13.   Thakre S, Anjankar A, Singh A, Kumar T. National Hypertension Guidelines: A Review of the India Hypertension Control Initiative (IHCI) and Future Prospects Introduction And Background. 2022.
• 14.   Fujiwara T, McManus RJ, Kario K. Management of hypertension in the digital era: Perspectives and future directions. HipertensRiesgoVasc. 2022 Apr-Jun;39(2):79-91. doi: 10.1016/j.hipert.2022.01.004. Epub 2022 Feb 21. PMID: 35210178.
• 15.   Nozato, Y., Yamamoto, K. The future of digital hypertension management to overcome clinical inertia. Hypertens Res 46, 1804–1806 (2023). https://doi.org/10.1038/s41440-023-01308-9
• 16.   Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. 2019;33(8):575-587.
• 17.   TsiouÀs C, Kordalis A, Flessas D, et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011;2011:1–7.
• 18.   American College of Sports Medicine. ACSM Physical Activity Guideline Executive Summary, 2019.
• 19.   Dimeo F, Pagonas N, Seibert F, et al. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension 2012;Sep:60:653–658.
• 20.   Dassanayake S, Sole G, Wilkins G, Skinner M. Exercise: a therapeutic modality to treat blood pressure in resistant hypertension. Physical Therapy Reviews. 2020 May 3;25(3):149-58.
• 21.   National Institute for Care and Excellence. Hypertension in adults: Diagnosis and managemen (CG 127). NICE Guidelines 2011 [cited]. https://www.nice.org.uk/guidance/cg127
• 22.   Jin YZ, Yan S, Yuan WX. Effect of isometric handgrip training on resting blood pressure in adults: a meta-analysis of randomized controlled trials. J Sports Med Phys Fit 2017;57:154–160.
• 23.   Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-1177.
• 24.   Mohan S, Campbell NRC. Hypertension management in India: a call to action. Can J Cardiol. 2019;35(11):1547-1553.
• 25.   Thankappan KR, Shah B, Mathur P, et al. Risk factor proÀle for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res. 2010;131:53-63.
• 26.   Joshi SR, Parikh RM. India - diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323-324.
• 27.   Prabhakaran D, Anand S, Watkins D, et al. Cardiovascular diseases in India: current epidemiology and future directions. Circulation. 2016;133(16):1605-1620.
• 28.   Xavier D, Gupta R. Hypertension in India: from awareness to control - an update. J Assoc Physicians India. 2013;61(12):8-11.
• 29.   Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18-26.
• 30.   Chobanian A V. The hypertension paradox - more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878-887.
• 31.   World Health Organization. A global brief on hypertension: silent killer, global public health crisis. Geneva: World Health Organization; 2013.
• 32.   World Health Organization (WHO). Global status report on noncommunicable diseases 2014.
• 33.   Gupta R et al. Prevalence of hypertension in India: A systematic review and meta-analysis. J Hypertens 2019;37(3):430-437.
• 34.   Ministry of Health & Family Welfare (MoHFW), Government of India. National Programme for Prevention & Control of Cancer Diabetes Cardiovascular Diseases & Stroke (NPCDCS)
• 35.   Chow CK et al. Effect of lifestyle-focused text messaging on risk factormodiÀcationinpatients with coronary heart disease: A randomized clinical trial. JAMA 2015;314 (12):1255-1263.
• 36.   Indian Council of Medical Research (ICMR). Guidelines for Management of Hypertension 2020.
• 37.   World Heart Federation (WHF). Roadmap for Hypertension Control: An Alliance for Global Action.
• 38.   Joshi SR et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India—results from the Screening India’s Twin Epidemic (SITE) study. Diabetes TechnolTher 2019;21(2):118-125. 39. Gupta R et al. Challenges in management of cardiovascular diseases in low-resource settings: A call for global action. J Am CollCardiol 2014;64(10):1056-1068.
• 40.   Indian Journal of Medical Research (IJMR). Special issue on Hypertension in India 2021;153(5).
• 41.   Patel V et al. The Lancet Commission on noncommunicable diseases in India: Strategies for improved outcomes.
• 42.   Indian Heart Association (IHA). Healthy Heart Program: A community-based initiative for cardiovascular disease prevention.

Data Sharing Statement

Funding